community pneumonia in our hospital. Recently promising new scoring system such as expanded-CURB-65 also known. This study aims to assess the CURB-65, expanded-CURB-65 and CURB-65 with addition low albumin and low platelet as a predictor of 30-days mortality of CAP patients in dr.Cipto Mangunkusumo National General Hospital.
Methods: This prospective cohort study involved 267 CAP patients who came to the Emergency Room (ER), pulmonary clinics or hospitalized in Dr. Cipto Mangunkusumo National General Hospital, Jakarta. The assessed outcome was patient mortality within 30 days. Performance of the CURB-65, expanded-CURB-65, and CURB-65 with addition low albumin and low platelet assessed using the area under the curve (AUC).
Results: During the 30-day period, there were 84 deaths (31.5%).
The AUC CURB-65, expanded-CURB-65 and CURB-65 with addition low albumin and low platelet, respectively were as follows: 0,733 (P value 0,0001), 0,796 (P value 0,0001), and 0,799 (P value 0,0001). Additional result from our study using bivariate analysis is Lactate Dehydrogenase (LDH) from the expanded-CURB-65 score does not predict 30 day mortality of CAP patients in our hospital.
Conclusion: CURB-65 score with addition low albumin and low platelet is simple, objective and more accurate scoring system for predicting the mortality in CAP patients, better than CURB-65 score and expanded-CURB-65. It also more cost effective than expanded-CURB-65. 
